PTEN deletion in luminal cells of mature prostate induces replication stress and senescence in vivo
Open accessThe DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Abstract
Genetic ablation of the tumor suppressor PTEN in prostatic epithelial cells (PECs) induces cell senescence. However, unlike oncogene-induced senescence, no hyperproliferation phase and no signs of DNA damage response (DDR) were observed in PTEN-deficient PECs; PTEN loss-induced senescence (PICS) was reported to be a novel type of cellular senescence. Our study reveals that PTEN ablation in prostatic luminal epithelial cells of adult mice stimulates PEC proliferation, followed by a progressive growth arrest with characteristics of cell senescence. Importantly, we also show that proliferating PTEN-deficient PECs undergo replication stress and mount a DDR leading to p53 stabilization, which is however delayed by Mdm2-mediated p53 down-regulation. Thus, even though PTEN-deficiency induces cellular senescence that restrains tumor progression, as it involves replication stress, strategies promoting PTEN loss–induced senescence are at risk for cancer prevention and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Although initially PTEN loss-induced cellular senescence was not associated with DDR activation40, it was later found to be associated with hyperproliferation, DDR engagement and cellular senescence in vivo41”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890 · cited 1×
“Pictures were edited with the Fiji software (Schindelin et al., 2012).”
MethodA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 3×
“…sections were cut, fixed in 2% formaldehyde and 0.2% glutaraldehyde, stained in 100 mM K3Fe(CN)6, 100 mM K4Fe(CN)6, 2 mM MgCl2, 150 mM NaCl, citric acid phosphate buffer (0.2 M Na2HPO4 and 0.1 M Citric acid), and 1 mg/ml X-gal (Roche) for 6 h and counterstained in hematoxylin (Dimri et al., 1995).”
BackgroundMethodInfluentialDNA double-stranded breaks induce histone H2AX phosphorylation on serine 139
Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., & Bonner, W. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5858 · Cited by 5,438 · cited 2×
“PTEN deficiency in PECs induces replication stress Because DDR is an inducer of OIS (Bartkova et al., 2006; Di Micco et al., 2006; Mallette et al., 2007), we investigated the levels of phosphohistone H2AX S139 (γH2AX), a faithful marker of DDR activation (Rogakou et al., 1998; Mah et al., 2010).”
BackgroundOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 3×
“…and Campisi, 2007; Courtois-Cox et al., 2008), including the expression of oncogenes in untransformed cells (e.g., RasG12V, E2F1, Raf, Mos, Cdc6, cyclin E, Stat5, and PML; Serrano et al., 1997; Ferbeyre et al., 2000; Michaloglou et al., 2005; Mallette et al., 2007; Courtois-Cox et al., 2008).”
BackgroundIn Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · cited 1×
“To demonstrate that Mdm2 was involved in p53 degradation at early time, PTEN(i) pe−/− mice were treated with Nutlin-3, an inhibitor of Mdm2–p53 interaction (Vassilev et al., 2004) 1 mo after PTEN ablation.”
MethodThe DNA damage response: putting checkpoints in perspective
Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213 · cited 3×
“Induction of the DDR stabilizes p53 through its phosphorylation by DDR kinases (ATR, ATM, DNA-PK, CHK1, and CHK2; Zhou and Elledge, 2000; Lavin and Gueven, 2006). p53 promotes OIS through transcriptional regulation of an array of genes, including p21, an inhibitor of cell cycle progression (Mirzayans et al., 2012).”
BackgroundBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993 · cited 15×
“Accordingly, markers of senescence have been observed in premalignant lesions in various human tissues, including the prostate, but not in the corresponding tumors (Chen et al., 2005; Michaloglou et al., 2005; Collado and Serrano, 2010; Vernier et al., 2011).”
BackgroundResultInfluentialOncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · cited 7×
“The DNA damage response (DDR) pathway is a central regulator of OIS (Bartkova et al., 2006; Bartek et al., 2007; Mallette et al., 2007; Courtois-Cox et al., 2008).”
BackgroundInfluentialOncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821 · cited 2×
“PTEN deficiency in PECs induces replication stress Because DDR is an inducer of OIS (Bartkova et al., 2006; Di Micco et al., 2006; Mallette et al., 2007), we investigated the levels of phosphohistone H2AX S139 (γH2AX), a faithful marker of DDR activation (Rogakou et al., 1998; Mah et al., 2010).”
Background
Cited by
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
Lai, P., Liu, L., Bancaro, N., Troiani, M., Calì, B., Li, Y., Chen, J., Singh, P. K., Arzola, R. A., Attanasio, G., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.03.005 · Cited by 174
Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications
Testa, U., Castelli, G., & Pelosi, E. (2019) · Medicines · doi:10.3390/medicines6030082 · Cited by 194
“The selective ablation of PTEN in prostatic luminal cells at adulthood induces the slow development of PIN lesions, characterized by an initial proliferation of prostate epithelial cells, followed by a progressive growth arrest with features of cell senescence [549].”
BackgroundA common signature of cellular senescence; does it exist?
Sikora, E., Bielak-Żmijewska, A., & Mosieniak, G. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101458 · Cited by 135
Skin-Aging Pigmentation: Who Is the Real Enemy?
Kim, J. C., Park, T. J., & Kang, H. Y. (2022) · Cells · doi:10.3390/cells11162541 · Cited by 135
“The loss of PTEN as a tumor suppressor can induce hyperproliferation with DDR, resulting in cellular senescence [74].”
BackgroundLiu, Y., Lomeli, I., & Kron, S. J. (2024) · Cells · doi:10.3390/cells13151281 · Cited by 77
“One study found that loss of the tumor suppressor PTEN induces DNA damage, leading to senescence in mouse prostate epithelial cells [57].”
BackgroundQiu, T., Tian, Y., Gao, Y., Ma, M., Li, H., Liu, X., Wu, H., Zhang, Y., Ding, H. J., Cao, M., et al. (2019) · Aging · doi:10.18632/aging.102262 · Cited by 64
“Genetic ablation of PTEN in prostatic epithelial cells induces cell senescence [21].”
BackgroundCellular senescence as a possible link between prostate diseases of the ageing male
Fiard, G., Stavrinides, V., Chambers, E. S., Heavey, S., Freeman, A., Ball, R., Akbar, A. N., & Emberton, M. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00496-8 · Cited by 62
el Maaty, M. A. A., Terzic, J., Keime, C., Rovito, D., Lutzing, R., Yanushko, D., Parisotto, M., Grelet, É., Namer, I. J., Lindner, V., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo2295 · Cited by 56
“As Pten (i)pe−/− PINs exhibit characteristics of cellular senescence at 3 months AGI ( 16 ), we determined the influence of HIF1A on senescence entry.”
Self-citationBarthet, V. J. A., Brucoli, M., Ladds, M. J. G. W., Nössing, C., Kiourtis, C., Baudot, A. D., O’Prey, J., Zunino, B., Müller, M., May, S., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf9141 · Cited by 56
KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis
Limberger, T., Schlederer, M., Trachtová, K., Alonso, I. G. D. L. F., Yang, J., Högler, S., Sternberg, C., Bystrý, V., Oppelt, J., Tichý, B., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01542-8 · Cited by 52
“This form of cell cycle arrest, which can be triggered upon oncogenic stress, is usually mediated via the p16INK4A-RB and the p14ARF-p53-p21CIP1 pathways and has previously been shown to act as a barrier to metastatic transformation in PCa [7].”
BackgroundBeyond Kinases: Targeting Replication Stress Proteins in Cancer Therapy
Baillie, K. E., & Stirling, P. C. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.10.010 · Cited by 43
Senescence of Tumor Cells in Anticancer Therapy—Beneficial and Detrimental Effects
Piskorz, W. M., & Cechowska‐Pasko, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911082 · Cited by 43
“Inhibited expression of cancer suppressors triggers cell proliferation arrest, as exemplified by PICS (phosphatase and tensin homolog deleted on chromosome ten (PTEN) loss-induced cellular senescence), which has recently also been proven to be associated with hyperproliferation and the DDR mechanism [30].”
BackgroundProstate luminal progenitor cells: from mouse to human, from health to disease
Baurès, M., Dariane, C., Tika, E., Lombardi, E. P., Delongchamps, N. B., Blanpain, C., Guidotti, J., & Goffin, V. (2022) · Nature Reviews Urology · doi:10.1038/s41585-021-00561-2 · Cited by 39
el Maaty, M. A. A., Grelet, É., Keime, C., Rerra, A., Gantzer, J., Emprou, C., Terzic, J., Lutzing, R., Bornert, J., LAVERNY, G., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg5982 · Cited by 32
Self-citationKim, S. G., Sung, J. Y., Kim, J.-R., & Choi, H. C. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111598 · Cited by 30
Autophagy and PTEN in DNA damage-induced senescence
Sharma, A., & Almasan, A. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.006 · Cited by 29
Pyruvate Kinase M1 Suppresses Development and Progression of Prostate Adenocarcinoma
Davidson, S. M., Heyman, J. E., O’Brien, J. P., Liu, A. C., Schmidt, D. R., Israelsen, W. J., Dayton, T. L., Sehgal, R., Bronson, R. T., Freinkman, E., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-2352 · Cited by 28
Potential molecular biomarkers for the diagnosis and prognosis of bladder cancer
Fan, J., Chen, B., Luo, Q., Li, J., Huang, Y. C., Zhu, M., Chen, Z., Li, J., Wang, J., Liu, L., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116312 · Cited by 24
NALCN‐mediated sodium influx confers metastatic prostate cancer cell invasiveness
Iamshanova, O., Gordienko, D. V., Folcher, A., Bokhobza, A., Shapovalov, G., Puthooru, D. K., Mariot, P., Allart, L., Desruelles, E., Spriet, C., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2022112198 · Cited by 21
Li, J., Li, Y., Zhou, L., Li, C., Liu, J., Liu, D., Fu, Y., Wang, Y., Tang, J. H., Zhou, L., et al. (2024) · Microbiological Research · doi:10.1016/j.micres.2023.127596 · Cited by 17
Cellular senescence in metastatic prostate cancer: A therapeutic opportunity or challenge (Review)
Jin, C., Liao, S., Lu, G., Geng, B. D., Ye, Z., Xu, J., Ge, G., & Yang, D. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13286 · Cited by 15
“Parisotto et al (54) demonstrated that PTen deficiency in adult mouse prostate luminal epithelial cells stimulated Pca epithelial proliferation, followed by progressive growth arrest characterized by cellular senescence. in a Pca mouse model, chen et al (55) demonstrated that double mutant mice with specific inactivat…”
BackgroundSenescence controls prostatic neoplasia driven by Pten loss
Parisotto, M., Grelet, É., Bizri, R. E., & METZGER, D. (2018) · Molecular & Cellular Oncology · doi:10.1080/23723556.2018.1511205 · Cited by 14
“To further characterize the impact of Pten loss in prostatic epithelial cells of the mature prostate, we analyzed PTEN mice, in which Pten is selectively ablated in prostatic luminal epithelial cells of mice after puberty.(6)”
BackgroundSelf-citationTargeting immunosenesence promotes clearance of senescent cells
Tizazu, A. M., Tessema, E. A., & Cexus, O. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00518-8 · Cited by 15
“Cellular division and DNA replication are highly regulated processes [39].”
Yanushko, D., German, B., Bizri, R. E., Pervizou, D., Dolgos, R., Keime, C., Ye, T., Thibault-Carpentier, C., Magnen, C. L., Henri, S., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07361-1 · Cited by 12
“…generated by intraperitoneal injection of Tamoxifen (1 mg/mouse/day) for 5 days to 8 to 10 week old PSA-CreER T2(Tg/0) / Pten L2/L2 , PSA-CreER T2(Tg/0) /Pten L2/L2 /Trp53 L2/L2 , PSA-CreER T2(0/0) /Pten L2/L2 and PSA-CreER T2(0/0) /Pten L2/L2 /Trp53 L2/L2 mice, respectively, as described [13, 14].”
Self-citationSallbach, J., Woods, M., Rasenberger, B., Christmann, M., & Tomicic, M. T. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117634 · Cited by 12
Cellular Senescence and Senolytic Agents: Recent Updates on Their Role and Applications
Chandrakar, L., Ambatwar, R., & Khatik, G. L. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266273698231107110956 · Cited by 11
Pervizou, D., Chiara, J. D., Spinelli, L., NESTOR-MARTIN, M., Chasson, L., LEN-TAYON, K., Yanushko, D., FIORE, F., Bajénoff, M., Malissen, B., et al. (2025) · OncoImmunology · doi:10.1080/2162402x.2025.2562220 · Cited by 7
“At PIN and adenocarcinoma stages, respectively 3 and 9 months after gene inactivation, the predominant infiltrating immune cells were Ly6G + neutrophils, previously characterized as Gr1 + MDSCs, 22 and F4/80 + macrophages (Figure 2(a–c)), which accumulate in the lumen and tumorous epithelium, and in the stroma respect…”
InfluentialSelf-citationCendra, A. S., Ospino, L. R., Pekarek, L., Dbouk, Y., Chnaiker, S., Luengo, A., Villamor, T., Corralo, A., Díaz, R., López-González, L., et al. (2025) · Journal of Cancer · doi:10.7150/jca.123907 · Cited by 2
“Loss of tumor suppressor genes such as PTEN has been linked to epithelial senescence in the bladder, functioning as a protective mechanism against tumor formation [38].”
Yanushko, D., Pichot, A., Vincent, A., Keime, C., LAVERNY, G., & METZGER, D. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08590-8 · Cited by 2
“Importantly, we provide evidence that pharmacological inhibition of HIF1 signaling represents a more potent therapeutic strategy against metastatic and hormone-refractory prostate cancer than those targeting myeloid chemotaxis.”
Self-citationImpaired vitamin D signaling reveals neutrophils as key drivers of prostate cancer dissemination
LEN-TAYON, K., Gantzer, J., Dariane, C., Fogel, O., Friedrich, V. C. R., Rovito, D., Lindner, V., Gilbart, V., Yanushko, D., Henri, S., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-026-00417-5 · Cited by 3
“Additionally, our previous work shows that enhanced proliferation induces replicative stress and senescence of PTEN-de fi cient PECs (Parisotto et al, 2018).”
Self-citationComment limiter la progression des tumeurs prostatiques déficientes en PTEN ?
Grelet, É., Parisotto, M., & METZGER, D. (2018) · médecine/sciences · doi:10.1051/medsci/2018224 · Cited by 1
Self-citationNETO2 promotes progression of prostate cancer by inhibiting the cellular senescence pathwayPreprint
Liu, Y., Xiang, Q., Ma, Y., Wang, Z., Pan, J., Wang, J., Zhou, M., Lin, J., Cai, Y., & Zhao, Z. (2022) · Research Square · doi:10.21203/rs.3.rs-1682664/v1
Espoir d’un nouveau traitement pour le cancer de la prostate résistant à la castration
Terzic, J., & METZGER, D. (2023) · médecine/sciences · doi:10.1051/medsci/2023117 · Cited by 1
Self-citationStudy of the role of the cyclin-dependent kinase inhibitor p21Waf1/Cip1 in cellular senescence
Zapata-Bodalo, I. (2022) · theses.fr (ABES) · doi:10.70675/db01e49aza2daz4404za0f1za3db90231ce9
Investigating cellular senescence during gliomagenesis
Salam, R. (2021) · theses.fr (ABES) · doi:10.70675/03e8bc79zd44ez4465z9b00ze8c0b82c28dc
Mécanismes ioniques dans l'adaptation tumorale
Folcher, A. (2023) · theses.fr (ABES) · doi:10.70675/04270336z7a70z430ez87ddz24d4d20241de
PTEN Knockout Causes Premature Senescence of Human Endometrial Stromal Cells
Parfenova, P. S., Deryabin, P. I., Pozdnyakov, D. Y., & Borodkina, A. V. (2024) · Cell and Tissue Biology · doi:10.1134/s1990519x24700330
“…which induction of senescence in response to suppression of PTEN expression is shown, in the case of EnSCs with PTEN knockout, senescence developed predominantly through the PI3K/AKT signaling pathway (Ali-monti et al., 2010; Duan et al., 2015; Parisotto et al., 2018a, 2018b; Jung et al., 2019).”
PTEN knockout leads to premature senescence of human endometrial stromal cells
Parfenova, P. S., Deryabin, P. I., Pozdnyakov, D. Y., & Borodkina, A. V. (2024) · Tsitologiya · doi:10.31857/s0041377124020035
Characterization of Pten and Trp53 deficient prostatic tumors in mice
Bizri, R. E. (2018) · theses.fr (ABES) · doi:10.70675/887a45dbz93f0z4790z9840z71a317de4d2f
Role of calcium during senescence response : A focus on prostate cancer
Mesilmany, L. (2022) · theses.fr (ABES) · doi:10.70675/ade2460az7f75z4fcfz8c1az66333eb1c7d1
Calcium Channels in Prostate Cancer Drug Resistance
Puthooru, D. K. (2025) · theses.fr (ABES) · doi:10.70675/2f003df4z6fcfz4df2za864z573fbb8c502a
Steinsdörfer, L., Zülch, L., Schäfer, A., Frey, B., Corradini, S., Fietkau, R., Gaipl, U. S., & Jost, T. (2026) · Strahlentherapie und Onkologie · doi:10.1007/s00066-026-02522-3
“Furthermore, reduced TIPE3 expression correlates with increased malignancy and unfavorable clinical outcomes in HNSCC [37, 38].”
Zhang, Q., Shen, K., & Liu, S. (2026) · Cells · doi:10.3390/cells15161457 · Cited by 1
“Activation of p53, p21 CIP1 , p16 INK4a , RB, and related tumor-suppressor pathways can enforce growth arrest and maintain tissue integrity [86,87,92–94 , 105 ].”
Peñarando, J., Willmann, D., Sum, M., Jia, Y., Berlin, C., Braun, L. M., Chen, Z., Urban, S., Jung, M., Duteil, D., et al. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02801-8
Self-citationThe role of the p53 signaling pathway in prostate cancer
Shi, R., Fu, H., Wang, X., Ye, C., Ji, X., Zhao, H., Zhang, Y., & 范迪辉 (2026) · Translational Andrology and Urology · doi:10.21037/tau-2026-0645
Metadata
- Authors
- Parisotto, M., Grelet, E., El Bizri, R., Dai, Y., Terzic, J., Eckert, D., Gargowitsch, L., Bornert, J.-M., & Metzger, D.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Centre National de la Recherche Scientifique UMR7104/Institut National de la Santé et de la Recherche Médicale U1258, Université de Strasbourg, Illkirch Cedex, France
- Corresponding author
- Metzger, Daniel
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2018-05-09
- Volume
- 215
- Issue
- 6
- Pages
- 1749-1763
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5987915
- OpenAlex
- W2802198289
- Cited by
- 43
- References
- 67
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 7 · 2023: 4 · 2022: 7 · 2021: 6 · 2020: 3 · 2019: 2 · 2018: 4
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Centre National de la Recherche Scientifique
- Institut National de la Santé et de la Recherche Médicale
- Université de Strasbourg
- Fondation ARC pour la Recherche sur le Cancer
- Ligue Contre le Cancer
- Alsace Contre le Cancer
- Association pour la Recherche sur les Tumeurs de la Prostate
- Centre d’Ingénierie Moléculaire Européen
- Agence Nationale de la Recherche (ANR-10-LABX-0030-INRT)
- Investissements d’Avenir (ANR-10-IDEX-0002-02)
- Association pour la Recherche à l’IGBMC
- Ministère de l’enseignement supérieur et de la recherché
- Al Bizri Foundation
- China Scholarship Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- PTEN, replication stress, DNA damage response, p53 stabilization, MDM2, cell proliferation, growth arrest, tumor suppressor, prostate cancer prevention
- MeSH terms
- Animals, DNA Damage, DNA Repair, Epithelial Cells, Male, Phenotype, Prostate, Prostatic Neoplasms, RNA, Messenger, Stress, Physiological, Biomarkers, Tumor, Signal Transduction, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, Cellular Senescence, Gene Deletion, Myeloid Cells, Cell Proliferation, Proto-Oncogene Proteins c-akt, PTEN Phosphohydrolase, Mice, Proto-Oncogene Proteins c-mdm2, Protein Stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.